Literature DB >> 1919150

Studies on endocrine changes induced by 8 MHz local radiofrequency hyperthermia in patients with bladder cancer.

T Hashimoto1, H Hisazumi, K Nakajima, F Matsubara.   

Abstract

To elucidate changes in hormone metabolism, especially thyroid, cortisol and sex hormone metabolism, during acute local heat stress, serum-free thyroxine (FT4), free tri-iodothyronine (FT3), reverse T3 (rT3), thyroxine binding globulin (TBG) and a number of other hormone levels [thyroid-stimulating hormone, thyroglobulin, calcitonine, luteinizing hormone, follicle-stimulating hormone, prolactin, growth hormone, cortisol and testosterone] were measured sequentially in 11 male patients with bladder cancer during and after local radiothermotherapy treatment. Hyperthermia was administered using 8 MHz radiofrequency (RF) capacity equipment. The core temperature was raised from 37 to 42 degrees C and maintained at 42 degrees C for 1 h. No significant change in hormone levels except for a slight decrease in TBG levels was observed. The clinical results indicated that 8 MHz RF hyperthermia at 42 degrees C can be applied safely as a therapeutic measure in patients with bladder tumours. Further studies concerning the changes in TBG are necessary in patients with other tumours, especially those with the complication of subclinical hyperthyroidism, to detect any corresponding rises in FT3 and FT4 levels. The effects of using higher temperatures also need to be examined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919150     DOI: 10.3109/02656739109034967

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  3 in total

1.  Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study.

Authors:  Tiago R Oliveira; Paul R Stauffer; Chen-Ting Lee; Chelsea D Landon; Wiguins Etienne; Kathleen A Ashcraft; Katie L McNerny; Alireza Mashal; John Nouls; Paolo F Maccarini; Wayne F Beyer; Brant Inman; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2013-09-19       Impact factor: 3.914

2.  Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer.

Authors:  Tiago R Oliveira; Paul R Stauffer; Chen-Ting Lee; Chelsea Landon; Wiguins Etienne; Paolo F Maccarini; Brant Inman; Mark W Dewhirst
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-02-26

Review 3.  Overview of bladder heating technology: matching capabilities with clinical requirements.

Authors:  Paul R Stauffer; Gerard C van Rhoon
Journal:  Int J Hyperthermia       Date:  2016-03-04       Impact factor: 3.914

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.